Pure Bioscience, Inc.
PURE· OTC
PUREPure Bioscience, Inc.
Filed Dec 14, 2023 · 10-Q · 44 days after period end · 0001493152-23-044859
| Metric | Q1 2024 | Q1 2023 | Q1 2022 | Q1 2021 |
|---|---|---|---|---|
| Revenue | $722.00K | $471.00K | $501.00K | $1.59M |
| Net Income | -$735.00K | -$993.00K | -$796.00K | -$180.00K |
| EPS Diluted | -$0.01 | -$0.01 | -$0.01 | $0.00 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Pure Bioscience, Inc. · CIK 1006028 · Engraved from SEC EDGAR
ended Oct 31, 2023 · filed Dec 14, 2023 · 44 d after period end
